| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/19/2002 | US20020132307 Humanized antibody for use in the treatment of infections, inflammation, autoimmune diseases and cancer |
| 09/19/2002 | US20020132299 Production of proteins by cell culture |
| 09/19/2002 | US20020132297 Nucleotide sequences coding protein for use in the treatment nflammatory bowel disease, sepsis, viral diseases and rheumatoid arthritis |
| 09/19/2002 | US20020132296 Human Ste20-like stress activated serine/threonine kinase |
| 09/19/2002 | US20020132289 Olfactory receptors and their utilizations |
| 09/19/2002 | US20020132271 Reagents, method and kit for detecting phosphinothricin-N-acetyltransferase protein |
| 09/19/2002 | US20020132262 Nucleotide sequences coding tumor suppressor protein for use in the diagnosis and treatment of cancer |
| 09/19/2002 | US20020132256 Diagnostic tools for analyzing ligand binding; obtain sample, incubate with reaction mixture, detect signal from bound lgand |
| 09/19/2002 | US20020132253 Nucleotide sequences coding membrane protein for use in diagnosis and treatment of athersclerosis, infections, arthritis, cancer, kidney and nervous system disorders |
| 09/19/2002 | US20020132252 Nucleotide sequences coding membrane protein for use in the diagnosis and treatment of infections, arthritis, nervous system and kidney disorders, cancer and atherosclerosis |
| 09/19/2002 | US20020132248 Generating nonradioactive marker for use in genetic analysis; obtain adjusted adaptor nucleotide sequences, incubate with target sequences, translated and recover protein |
| 09/19/2002 | US20020132240 Nucleotide sequences coding membrane proteins for use in treatment of cancer, infections, cardiavascular, nervous system, skin and kidney disorders |
| 09/19/2002 | US20020132237 Detecting ovarian cancer humans; obtain sample, incubate with preferential oligonucleotides, monitor hybridization, compare to control, evaluate for cancer |
| 09/19/2002 | US20020132233 Diagnostic reagent for use in the detection of cancer |
| 09/19/2002 | US20020132228 Phage antibodies |
| 09/19/2002 | US20020131970 Fibrinogen homolog capable of binding to endothelial cells in an arginine-glycine-aspartic acid (RGD)-independent manner that inhibits fibrinogen binding to endothelial cells; inhibiting tumor metastasis |
| 09/19/2002 | US20020131968 An Immunoglobulin G (IgG) antibody with binding affinity for the CD3 antigen in which the heavy chain has a variable region framework together with specified complementary determining region (CDR); immunosuppressant, treating cancer |
| 09/19/2002 | US20020131967 Such as melphalan and an anti-interleukin-6 receptor antibody, administering in synergistic amounts |
| 09/19/2002 | US20020131966 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs |
| 09/19/2002 | US20020131955 Interleukin antagonists for the treatment of neurological, retinal and muscular disorders |
| 09/19/2002 | US20020131954 Interleukin antagonists for the treatment of neurological, retinal and muscular disorders |
| 09/19/2002 | CA2692552A1 Novel protein isolated from pleurotus cornucopiae |
| 09/19/2002 | CA2441495A1 Proteins associated with cell growth, differentiation, and death |
| 09/19/2002 | CA2441082A1 Steap-related protein |
| 09/19/2002 | CA2440974A1 High affinity integrin polypeptides and uses thereof |
| 09/19/2002 | CA2440618A1 Immunoglobulin superfamily proteins |
| 09/19/2002 | CA2440345A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 09/19/2002 | CA2440221A1 Expression technology for proteins containing a hybrid isotype antibody moiety |
| 09/19/2002 | CA2440131A1 Antibodies against human igg total fraction, and uses thereof in neutralising and treating hiv-1 |
| 09/19/2002 | CA2439702A1 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof |
| 09/19/2002 | CA2439637A1 Human serpin polypeptides |
| 09/19/2002 | CA2437963A1 Therapeutic binding molecules |
| 09/19/2002 | CA2437960A1 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 09/19/2002 | CA2437958A1 Polymeric immunoglobulin fusion proteins that target low-affinity fc.gamma.receptors |
| 09/19/2002 | CA2437756A1 Nucleic acid-associated proteins |
| 09/19/2002 | CA2434762A1 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections |
| 09/19/2002 | CA2433353A1 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 09/18/2002 | EP1241269A2 Method for detecting REG-like protein and nucleic acids coding therefor |
| 09/18/2002 | EP1241264A1 Monoclonal antibodies to colon cancer antigen |
| 09/18/2002 | EP1241258A2 Stem cell factor |
| 09/18/2002 | EP1241256A1 Novel gene and use thereof |
| 09/18/2002 | EP1241252A2 Human enteropeptidase-like protein and nucleic acids encoding it |
| 09/18/2002 | EP1241251A2 Human prostasin-like protein and nucleic acids encoding the same |
| 09/18/2002 | EP1241250A2 Human dehydrogenase-like protein and nucleic acid encoding it |
| 09/18/2002 | EP1241187A2 Fibilin-like polypeptide and nucleic acids encoding the same |
| 09/18/2002 | EP1241186A2 Human growth arrest specific gene 6 (gas-6) and nucleic acids encoding the same |
| 09/18/2002 | EP1241185A2 Human protocadherin-like protein and nucleic acids encoding it |
| 09/18/2002 | EP1241184A2 Human synaptogyrin-like protein and nucleic acids encoding the same |
| 09/18/2002 | EP1241183A2 HUman HCAR-like protein and nucleic acids encoding it |
| 09/18/2002 | EP1241180A2 Human A33 antigen-like protein and nucleic acids encoding it |
| 09/18/2002 | EP1240521A2 Identification of disease markers involving mass-based-separation |
| 09/18/2002 | EP1240519A2 Compositions and methods for detecting treponema pallidum |
| 09/18/2002 | EP1240361A1 Method for detecting replication competent viruses in the sera of subjects receiving gene therapy |
| 09/18/2002 | EP1240350A1 P2y12 receptor |
| 09/18/2002 | EP1240337A2 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 09/18/2002 | EP1240335A2 Proteases |
| 09/18/2002 | EP1240332A2 Streptococcus pyogenes virulence genes and proteins and their use |
| 09/18/2002 | EP1240331A2 i CHLAMYDIA /i ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 09/18/2002 | EP1240330A2 i PSEUDOMONAS AERUGINOSA /i ANTIGENS |
| 09/18/2002 | EP1240329A2 i STREPTOCOCCUS PNEUMONIAE /i ANTIGENS |
| 09/18/2002 | EP1240328A1 Antigenic protein lppq of mycoplasma mycoides subsp. mycoides sc., its preparation and use |
| 09/18/2002 | EP1240327A2 Interferon-like molecules and uses thereof |
| 09/18/2002 | EP1240326A2 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
| 09/18/2002 | EP1240325A2 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
| 09/18/2002 | EP1240324A2 Polypeptides and nucleic acids encoding same |
| 09/18/2002 | EP1240319A1 Shotgun scanning, a combinatorial method for mapping functional protein epitopes |
| 09/18/2002 | EP1240313A2 Homologues of human heparanase and splice variants thereof |
| 09/18/2002 | EP1240298A2 Detergent compositions comprising benefit agents |
| 09/18/2002 | EP1240197A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP1240196A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 09/18/2002 | EP1240195A2 Polynucleotides and polypeptides encoded thereby |
| 09/18/2002 | EP1240194A2 Novel human protein kinases and protein kinase-like enzymes |
| 09/18/2002 | EP1240193A2 Peptide fragments of colostrinin |
| 09/18/2002 | EP1240191A1 P. gingivalis antigenic composition |
| 09/18/2002 | EP1240189A2 Hepatitis virus sentinel virus i (svi) |
| 09/18/2002 | EP1240183A2 Mammalian genes; related reagents and methods |
| 09/18/2002 | EP1239874A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 09/18/2002 | EP1239870A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 09/18/2002 | EP1239869A2 Tweak receptor |
| 09/18/2002 | EP1088095A4 Novel molecules of the t110-related protein family and uses thereof |
| 09/18/2002 | EP0981748A4 Signal enhancement of bispecific antibody-polymer probe for immunoassay use |
| 09/18/2002 | EP0873132A4 PROTEIN WHICH INTERACTS WITH THE HUNTINGTON'S DISEASE GENE PRODUCT, cDNA CODING THEREFOR, AND ANTIBODIES THERETO |
| 09/18/2002 | EP0842267B1 Mch2, AN APOPTOTIC CYSTEINE PROTEASE, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME |
| 09/18/2002 | EP0789763B1 Icam-4 materials and methods |
| 09/18/2002 | EP0693936B1 Cloned leptospira outer membrane protein |
| 09/18/2002 | EP0614486B1 Targeted delivery of virus vector to mammalian cells |
| 09/18/2002 | EP0592582B1 Monoclonal antibody to lymphocyte-associated cell surface protein |
| 09/18/2002 | CN1370238A Human poly(ADP-ribose) polymerase 2 materials and methods |
| 09/18/2002 | CN1370233A ERS-genes, method of screening for chemical compounds capable of inducing ERS in plants |
| 09/18/2002 | CN1370231A CASB618 polynucleotides and polypeptides and their use |
| 09/18/2002 | CN1370182A Compounds and methods for therapy and diagnosis of lung cancer |
| 09/18/2002 | CN1370082A Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies |
| 09/18/2002 | CN1370078A Prion protein peptides and uses thereof |
| 09/18/2002 | CN1370076A HM 1.24 antigen expression potentiators |
| 09/18/2002 | CN1369506A Human Protein for promoting transform of 3T3 cell and its coding sequence |
| 09/18/2002 | CN1369505A Human protein for promoting transform of 3T3 cell and its coding sequence |
| 09/17/2002 | US6451997 Kits for detecting chromosomal rearrangements |
| 09/17/2002 | US6451995 Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods |
| 09/17/2002 | US6451994 Polypeptides, polynucleotides; drug screening; diagnosing alzheimer*s, parkinson*s, huntington*s, and creutzfelt-jacob disease; amyotrophic lateral sclerosis, cystic fibrosis |
| 09/17/2002 | US6451984 Hybridoma made by fusion thymidine kinase-deficient myeloma with spleen cells immunized with eimeria sporozoite antigen |